The dangerous health business (2018) and The Bleeding Edge (2018): exposing corruption in biomedical research
Abstract The documentaries The dangerous health business (2018) and The Bleeding Edge (2018) highlight the risk of corruption that may exist in the biomedical research process, specifically in the development and subsequent approval of medical devices. This industry moves millions of euros per year and therefore can be governed by the logic of profit at the expense of injuries, suffering and death of patients who, with the need to use devices, receive those that are profitable but not effective and safe. This audiovisual material collects cases that require a reflection on the sense of devices invention that should be to improve the health-illness process of people and not the pockets of manufacturers. In that sense, complaints from the media should favor a self-criticism for each individual became capable of reflecting on their own actions and, in a near future, a new collective spirit without corruption be developed.
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
De Vaan M. Etymological Dictionary of Latin and the other Italic Languages. Leiden: Brill; 2008.
Homedes N, Ugalde A. La globalización de la investigación clínica en América Latina. En: Homedes N, Ugalde A, editores. Ética y ensayos clínicos en América Latina. Buenos Aires: Lugar Editorial, 2012: 81-111.
Hulstaert F, Neyt M, Vinck I, Stordeur S, Hui? M, Sauerland S, et al. Pre-market Clinical Evaluations of Innovative High-Risk Medical Devices in Europe. Int J Technol Assess Health Care. 2012; 28(3): 278-84.
Klimczak AM. Snyder RR, Borahay MA, Phelps JY. Medicolegal Review: Essure Lawsuits and Legal Strategies Adverse to Gynecologists. J Minim Invasive Gynecol. 2017;24(5):727-30.
Pellerin C. An Analysis of Foot and Ankle Device Recalls by the Food and Drug Administration. Cureus, 2018; 10(8): e3123.
Ross J, Keyhani S, Korenstein D. Appropriateness of Collaborations between Industry and the Medical Profession: Physicians’ Perceptions. Am J Med. 2009; 122(10): 955-60.
Sastry A. Overview of the US FDA Medical Device Approval Process. Curr Cardiol Rep, 2014; 16(6): 494.
Tower S. Arthroprosthetic Cobaltism: Neurological and Cardiac Manifestations in Two Patients with Metal-on-Metal Arthroplasty. J Bone Joint Surg Am. 2010; 92(17): 2847-51.
Homedes N, Ugalde A. La globalización de la investigación clínica en América Latina. En: Homedes N, Ugalde A, editores. Ética y ensayos clínicos en América Latina. Buenos Aires: Lugar Editorial, 2012: 81-111.
Hulstaert F, Neyt M, Vinck I, Stordeur S, Hui? M, Sauerland S, et al. Pre-market Clinical Evaluations of Innovative High-Risk Medical Devices in Europe. Int J Technol Assess Health Care. 2012; 28(3): 278-84.
Klimczak AM. Snyder RR, Borahay MA, Phelps JY. Medicolegal Review: Essure Lawsuits and Legal Strategies Adverse to Gynecologists. J Minim Invasive Gynecol. 2017;24(5):727-30.
Pellerin C. An Analysis of Foot and Ankle Device Recalls by the Food and Drug Administration. Cureus, 2018; 10(8): e3123.
Ross J, Keyhani S, Korenstein D. Appropriateness of Collaborations between Industry and the Medical Profession: Physicians’ Perceptions. Am J Med. 2009; 122(10): 955-60.
Sastry A. Overview of the US FDA Medical Device Approval Process. Curr Cardiol Rep, 2014; 16(6): 494.
Tower S. Arthroprosthetic Cobaltism: Neurological and Cardiac Manifestations in Two Patients with Metal-on-Metal Arthroplasty. J Bone Joint Surg Am. 2010; 92(17): 2847-51.
Zapata Ospina, J. P. . (2020). The dangerous health business (2018) and The Bleeding Edge (2018): exposing corruption in biomedical research. Journal of Medicine and Movies, 16(4), 255–260. https://doi.org/10.14201/rmc2020164255260
Downloads
Download data is not yet available.
+
−